Evidence map›Paper›PMID 35566344›Full record

ArticleMolecules (Basel, Switzerland)2022

The Role of the Nucleotides in the Insertion of the bis-Molybdopterin Guanine Dinucleotide Cofactor into apo-Molybdoenzymes.

Kim Tiedemann, Chantal Iobbi-Nivol, Silke Leimkühler

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. One Hundred Years of Sulfido Ligand in the Molybdenum Cofactor: New Perspectives.Chembiochem : a European journal of chemical biology · 2026
    Review
  2. Transformation of tetranuclear [{MoOChemical communications (Cambridge, England) · 2026
    Article
  3. Draft genome sequences of 12Microbiology resource announcements · 2025
    Article
  4. Article
  5. Article
  6. The History of the Molybdenum Cofactor-A Personal View.Molecules (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Kim TiedemannInstitute of Biochemistry and Biology, Molecular Enzymology, University of Potsdam, Karl-Liebknecht Str. 24-25, 14476 Potsdam-Golm, Germany.
Chantal Iobbi-NivolLaboratoire de Bioénergétique et Ingénierie des Protéines, Institut de Microbiologie de la Méditerranée, Centre National de la Recherche Scientifique, Aix-Marseille Université, CEDEX 09, 13402 Marseille, France.ORCID 0000-0002-2462-3283
Silke LeimkühlerInstitute of Biochemistry and Biology, Molecular Enzymology, University of Potsdam, Karl-Liebknecht Str. 24-25, 14476 Potsdam-Golm, Germany.
University of Potsdam · DEAix-Marseille Université · FR

Funding

Deutsche Forschungsgemeinschaft EXC 2008 - 390540038
6 · The paper itself

Abstract

The role of the GMP nucleotides of the bis-molybdopterin guanine dinucleotide (bis-MGD) cofactor of the DMSO reductase family has long been a subject of discussion. The recent characterization of the bis-molybdopterin (bis-Mo-MPT) cofactor present in the

Indexed as

Escherichia coliMetalloproteinsCoenzymesGuanine NucleotidesMolybdenumNucleotidesPterinsCoenzymesGuanine NucleotidesMetalloproteinsMolybdenummolybdopterin guanine dinucleotideNucleotidesPterinsbis-MGDchaperonemolybdenum cofactorTMAO reductase

Identifiers

PMID35566344
PMCPMC9103625
OpenAlexW4229373687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.